Oncogenesis.ai provides pre-trial hypothesis stress testing for oncology programs, helping biotech and pharma teams identify where biological assumptions may fail before costly clinical escalation.

Most cancer programs do not fail due to execution alone. They fail earlier — at the level of mechanism validity, biomarker alignment, or context transfer. These risks are often not explicitly tested before clinical development.

We analyze mechanism coherence, structural causality, trial-design fragility, and pre-trial evidence stability to expose hidden weaknesses in a program’s biological rationale. Our work is delivered as a structured advisory memo, designed to support clear, high-stakes decision-making.

We do not predict success.
We identify where a hypothesis breaks.

ONCOGENESIS.AI

Org chart

Teams

Offices

ONCOGENESIS.AI

Org chart

Teams

Offices

Related companies